| __timestamp | CymaBay Therapeutics, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15823000 | 241751000 |
| Thursday, January 1, 2015 | 17026000 | 322292000 |
| Friday, January 1, 2016 | 15941000 | 344320000 |
| Sunday, January 1, 2017 | 18938000 | 374644000 |
| Monday, January 1, 2018 | 58124000 | 414604000 |
| Tuesday, January 1, 2019 | 83837000 | 466000000 |
| Wednesday, January 1, 2020 | 35882000 | 535000000 |
| Friday, January 1, 2021 | 64542000 | 643000000 |
| Saturday, January 1, 2022 | 67995000 | 833000000 |
| Sunday, January 1, 2023 | 80118000 | 899625000 |
| Monday, January 1, 2024 | 901530000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Ionis Pharmaceuticals consistently outpaced CymaBay, with R&D expenses peaking at nearly $900 million in 2023, a staggering 900% increase from 2014. In contrast, CymaBay's R&D spending grew by approximately 400% over the same period, reaching $80 million in 2023. This strategic focus on R&D underscores Ionis's aggressive pursuit of groundbreaking therapies, while CymaBay's more measured approach reflects a balanced strategy. As these companies continue to innovate, their R&D investments will likely play a pivotal role in shaping the future of biotechnology.
Research and Development Investment: Gilead Sciences, Inc. vs CymaBay Therapeutics, Inc.
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
R&D Insights: How CymaBay Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds